Tenderwize
Zurück zur Suche

Pharmaceutical Products

Amgros I/S·København Ø, Denmark·DKK 1564M | EUR 209.2M·Deadline Sep 03, 2026 · 34 days left·Open·Supplies
High valueStructured notice only
Originaltitel der Bekanntmachung

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

80/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

80 / 100

Komplexität

30 / 100

Risikofaktoren

The stated estimated quantities are indicative only. Actual demand may be lower or higher based on patient needs and tr...

The framework is non-exclusive and without purchase obligation. The buyer may purchase from other sources even if you w...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Strong opportunity

Wichtige Fakten

  • DKK 1564M estimated value
  • Supplies contract
  • 2 lots
  • Duration until Dec 2028
  • Supply of Daratumumab (ATC L01FC01) in two different formulations and strengths.
  • Lot 1: 1800 mg injection, estimated 610,073 units.
Vollständige Zusammenfassung anzeigen

This is an open tender (framework agreement) by Amgros I/S for the supply of pharmaceutical products (Daratumumab) to Danish public hospital pharmacies. The tender is divided into two separate lots, each representing a different product form/dosage. Award is based solely on price (100% weight). No minimum eligibility requirements are imposed. The total estimated framework value is DKK 1,564,000,000 (approx. EUR 208,873,981). The procurement is EU-funded and conducted under Directive 2014/24/EU. Submission is electronic via a portal, with a deadline of 2026-09-03. Important: no procurement documents were analyzed; all data comes from the structured notice and XML notice.

Risiken

The stated estimated quantities are indicative only. Actual demand may be lower or higher based on patient needs and tr...

The framework is non-exclusive and without purchase obligation. The buyer may purchase from other sources even if you w...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Open procedure for a framework agreement.
  • Variants are not allowed.

Administrative

  • Tenders must be submitted electronically via Amgros procurement portal.

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

100% price – lowest price wins.100%

Lot 2

100% price – lowest price wins.100%

Auftraggeber

Ort

København Ø, DNK

Auftraggeberprofil

Profil öffnen

Kennung

14479880

Tätigkeit

Health

Lose (2)

LOT-0001

Tender No. 1

Supply of Daratumumab injection 1800 mg, estimated 610,073 units. Framework agreement with no purchase obligation. Real consumption may vary significantly from estimates.

SuppliesFrameworkEU fundedElectronic submission

EUR 209.2M

Geschätzter Wert

Ort

DK011, Denmark

Dauer

Dec 2026 - Dec 2028

Kategorie

Pharmaceutical products

Zuschlagskriterien

Price

LOT-0002

Tender No. 2

Supply of Daratumumab infusion 20 mg/ml in two pack sizes (5 ml and 20 ml), combined estimated 712 units. Framework agreement with no purchase obligation. Real consumption may vary.

SuppliesFrameworkEU fundedElectronic submission

EUR 209.2M

Geschätzter Wert

Ort

DK011, Denmark

Dauer

Dec 2026 - Dec 2028

Kategorie

Pharmaceutical products

Zuschlagskriterien

Price

Vergabedetails

Veröffentlichungsdatum
09 Jul 2026
Sprachen
Danish, Swedish

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
477000-2026

Dokumente (1)

Ähnliche Ausschreibungen